Dimerix Limited Banner Image

Dimerix Limited

  • Ticker DXB
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Dimerix Limited Logo Image
  • 1-10 Employees
  • Based in Fitzroy, Australia
Dimerix Limited, a clinical-stage biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. The company develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; and DMX-700 that is in pre-clinical development for chronic obstructiveMore pulmonary disease. The company was founded in 2004 and is headquartered in Fitzroy, Australia.
4.8 / 5.0 (56)

Dimerix Limited reports have an aggregate usefulness score of 4.8 based on 56 reviews.

Dimerix Limited

Most Recent Annual Report

Dimerix Limited
MOST RECENT 2020 Annual Report

Older/Archived Annual Reports

Dimerix Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!